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ABSTRACT
With the rise of multi-drug resistant pathogens and
the decline in number of potential new antibiotics
in development there is a fervent need to reinvig-
orate the natural products discovery pipeline. Most
antibiotics are derived from secondary metabolites
produced by microorganisms and plants. To avoid
suicide, an antibiotic producer harbors resistance
genes often found within the same biosynthetic
gene cluster (BGC) responsible for manufacturing
the antibiotic. Existing mining tools are excellent
at detecting BGCs or resistant genes in general,
but provide little help in prioritizing and identifying
gene clusters for compounds active against spe-
cific and novel targets. Here we introduce the ‘An-
tibiotic Resistant Target Seeker’ (ARTS) available at
https://arts.ziemertlab.com. ARTS allows for specific
and efficient genome mining for antibiotics with inter-
esting and novel targets. The aim of this web server
is to automate the screening of large amounts of se-
quence data and to focus on the most promising
strains that produce antibiotics with new modes of
action. ARTS integrates target directed genome min-
ing methods, antibiotic gene cluster predictions and
‘essential gene screening’ to provide an interactive
page for rapid identification of known and putative
targets in BGCs.
INTRODUCTION
The alarming number of antibiotic resistant pathogens and
the declining rate of novel antibiotics discovered makes the
search for new antibiotic compounds one of the most im-
portant tasks of this century. The majority of drugs in the
clinic has been and continues to be inspired by bioactive
compounds produced as secondarymetabolites by living or-
ganisms (1–3). These so-called natural products have been
isolated from a variety of sources including plants, fungi
and bacteria. Soil dwelling bacteria of the phylum Acti-
nobacteria have particularly been shown to be a rich source
for a variety of novel compounds with diverse bioactivities
(4). It is remarkable that this reservoir of discovery has only
been the product of some 1% of cultivable bacteria, many
of which harbor still untapped genetic potential (1).
Traditionally, drug discovery has been largely based on
bioactivity-guided methods. More recently, with the advent
of next generation sequencing, genome-based methods in-
vigorate new drug discovery efforts (5). Genome mining re-
vealed that many bacteria previously believed to not pro-
duce natural products harbor dormant potential and that
even well studied sources contain orphan biosynthetic gene
clusters (BGCs), with products yet to be discovered (6).
Automated genome mining tools such as antiSMASH (7)
and PRISM (8), as well as databases such as MIBiG (9)
or the antiSMASH database (10), along with methods such
as EvoMining (11), allow for effective and fast mining of
the thousands of available bacterial genomes. The current
largest collection of automatically mined gene clusters is
the “Atlas of Biosynthetic gene Clusters”, a component
of the “Integrated Microbial Genomes” Platform of the
Joint Genome Institute (JGI IMG-ABC) (12). As of Jan-
uary 2017 this database contains more than a million gene
clusters, themajority of them orphan. The biggest challenge
now is to prioritize the more laborious wet lab experiments
for BGCs with the most promising bioactivities.
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One recently developed approach for the specific discov-
ery of new antibacterial compounds uses resistance as a
trait for selecting for antibiotic producing bacteria. Any
bacterium producing an antibiotic needs to evolve a self-
protection mechanism to avoid suicide (13). Based on this
idea, Wright et al. designed a screen to exploit the self-
protection mechanism of antibiotic producers to enrich mi-
crobial libraries for producers of selected antibiotic scaf-
folds (14). Resistance mechanisms vary and include the in-
activation and export of antibiotics, as well as protection
and modification of target proteins. In the latter case a
second resistant copy of the antibiotic target gene is typ-
ically detectable in the genome, often found within the
BGC of the antibiotic and often horizontally acquired with
the BGC (15–17). Moore and colleagues used this con-
cept and screened for duplicated housekeeping genes co-
localized with orphan BGCs. Using this target-directed
genome mining, they were able to prioritize an orphan
polyketide synthase-nonribosomal peptide synthetase hy-
brid BGC, responsible for producing a fatty-acid synthase
inhibitor, containing a fatty acid synthase resistance gene
(18). This study demonstrated nicely that the search for
BGCs in conjunction with duplicated housekeeping genes
can not only help prioritize BGCs with antibiotic activities,
but also provide insights into themode of action of encoded
natural products.
So far, this search has been done manually, checking
each detected gene cluster for possible resistant housekeep-
ing genes. Here we introduce the antibiotic resistant target
seeker (ARTS), a user-friendly web tool that automatically
detects known resistance, as well as possible resistant house-
keeping genes in actinobacterial genomes based on three
criteria: duplication, localization within a biosynthetic gene
cluster and evidence of horizontal gene transfer (HGT).
ARTS allows the user a fast and efficient genome-based pri-
oritization of bacterial strains with the potential to produce
antibiotics with interesting and possibly novel modes of ac-
tion.
MATERIALS AND METHODS
Workflow
The ARTS workflow in Figure 1 illustrates automated steps
for known resistance screening and novel target analysis.
Users provide DNA sequences of whole genomes or gene
clusters in Genbank, FASTA or EMBL format as input;
alternatively an NCBI accession number or antiSMASH
job id can be used to retrieve data automatically. The first
steps include identifying BGCs using antiSMASH, detect-
ing known resistancemodels (19–22) and detecting essential
core genes (see reference set and core gene detection). Dur-
ing the next steps the identified core and known resistance
genes are screened for their location within BGCs. Finally
core genes are screened for HGT. All screening results are
then summarized into an interactive output table to rapidly
cross reference known and putative novel targets.
Reference set and core gene detection
A reference set of complete genomes is used to identify es-
sential genes, define duplication thresholds and infer HGT
via species and gene tree reconciliation. The current Acti-
nobacteria reference set is comprised of complete genomes
from 189 species representing 22 different families that are
available through NCBI’s RefSeq (23) database (Supple-
mentary File S1). Core genes are identified using protein
families from the TIGRFAM database, where all protein
models that are found in the vast majority of reference
genomes are considered core genes. Unless ‘exploration
mode’ is used, core genes are filtered for unlikely targets by
removing regulatory, transport and biosynthetic functions
associated with known BGCs. To facilitate HGT detection
in later steps, alignments and gene trees are then built as
detailed in the Supplementary Methods.
Screening criteria
BGC proximity. BGCs are detected using antiSMASH v3.
Then core and resistance genes with intersecting locations
on the same scaffold are marked as BGC proximity hits.
These are presented in the visual cluster annotation as well
as in the interactive summary tables.
Gene duplication. Duplication thresholds are determined
comparatively using the sum of median and standard de-
viation for each essential gene count in the reference set.
All core genes over these thresholds are then marked and
recorded in the summary and duplication sections.
HGT. Phylogenetic screening is used to highlight all query
organism core genes that show evidence of HGT. This is ac-
complished by comparing core gene trees with the species
tree to highlight incongruences. This consists of first build-
ing alignments and trees for all core genes. A species tree is
then inferred using ubiquitous, single copy gene trees with
a coalescent tree analysis. Incongruent gene trees that are
more likely explained by HGT, instead of duplications and
losses through generations, is then determined as detailed
in the Supplementary Methods.
Input options
Users can provide custom essential genes and resistance
models for more tailored searches using the upload sections
in the advanced dropdown; essential gene search thresholds
can be modified in this section as well. Options to disable
certain screening criteria are available to accelerate analysis
and can be helpful for certain input, such as disabling phy-
logenetic screening for non-reference phyla genomes. By de-
fault, all criteria and trusted cutoffs are used and currently
the phylogenetic reference set is selected for Actinobacteria.
Non-actinobacterial genomes can be submitted for analysis
however the phylogeny criteria will not be applicable. The
option for ‘explorationmode’ is used for an extended search
which may include more false positives but screens a larger,
unfiltered, set of core genes.
Output and interactive layout
The results are presented in various sections by criteria per-
spectives: core genes, resistance models, gene duplications,
BGC proximity and phylogeny. Dynamic tables in sections
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Figure 1. Workflow of the ARTS pipeline. Input query genome sequences and reference organisms are scanned for Biosynthetic Gene Clusters (BGCs),
known resistance factors and essential genes. Screening criteria for duplication, co-localization with BGCs and phylogeny are then applied and integrated
into the interactive output for target directed BGC prioritization and novel target discovery.
can be searched and sorted allowing for rapid prioritization
of properties and their combinations (Figure 2). For exam-
ple, sorting the core gene table by positive BGC hits and
phylogeny will yield all core genes found in a BGC with
incongruent phylogeny. Details for each item can be inves-
tigated by expanding a row to reveal links to correspond-
ing sections. Visualizations for cluster annotations and trees
highlighting the query organism are also generated for rapid
confirmation of these criteria. All tables, trees and core gene
alignments can be exported and saved for additional analy-
sis from the export section. Additional metadata are pro-
vided to assess the viability of a novel target prediction
which include: functional classification, average selection
pressure (dN/dS) values and how widespread the essential
gene is relative to reference organisms (ubiquity). This can
help eliminate less promising drug target predictions, such
as one that is not universally shared. Examples of all inputs
and detailed tutorials on output interpretation can be found
at https://arts.ziemertlab.com/help.
RESULTS
Here we present ARTS, an easy to use web tool for the
high-throughput screening of bacterial genomes for their
potential to produce antibacterial compounds with inter-
esting modes of action. To our knowledge, ARTS is cur-
rently the only public web server that automates an ex-
tended target-directed genome mining that includes poten-
tially novel targets. It demonstrates significantly increased
throughput compared to manual target-directed methods
and allows for intuitive visualizations and rapid explo-
rations of several resistance factors. A manual phylogenetic
analysis of all core genes, with alignments and Maximum-
Likelihood tree construction, took over 89 h of process-
ing time alone on a 16-core machine. By leveraging the
pre-computed reference, the analysis took 15 min using the
same resources with ARTS. Aside from processing time, the
interactive browser format proved to bemore accessible and
faster to interpret than manual methods. The ARTS web
server and analysis scripts are available to the public with
git repository at: https://bitbucket.org/ziemertlab/arts
Reference set and core gene analysis
To verify that core genes inferred from reference organ-
isms are essential, comparisons to experimental examples
and properties of essential genes were interrogated. A to-
tal of 664 essential gene models (Supplementary File S2)
are identified using the core genome methods and 432 re-
main when filtered as detailed in the Supplementary Meth-
ods. Comparison to the experimentally confirmedDatabase
of Essential Genes (24) (DEG) v13 shows 538 genes in the
set match to one or more records. Functional classification
reveals that the majority of genes not found in DEG are
in unknown, unclassified, or energy and metabolism cate-
gories (Supplementary File S3). Additionally, all reference
core gene hits, compared to all TIGRFAM hits, showed en-
richment for essential functions such as: protein and amino
acid synthesis, energy and metabolism, and transcription
(Supplementary File S4). A variety of approaches to deter-
mine essential genes can be found in literature where ubiq-
uity and conservation of sequence are properties frequently
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Figure 2. Example output screenshot highlighting three major sections: core gene table prioritization, BGC visualization and phylogenetic incongruence
confirmation.
exploited (25–27).Nearly all of the set share these properties
(Supplementary File S5) with a dN/dS mode of 0.35 and
range of 0.05–1.05 illustrating strong purifying selection.
While more than half of the genes are present in over 90% of
genomes, many are specific to certain genera. One example
is the 20S proteasome, which is essential tomany actinobac-
terial genera but is lacking in others with only 64% global
reference ubiquity. By defining core genes relative to family,
this specific function is captured. All resulting trees showed
valid branch support (Supplementary S6) with single copy
gene trees showing monophyletic groupings.
Detection frequency and false positives
To estimate false positive rates, total hit frequencies for
BGCs and complete genome sequences were evaluated as
a proxy due to the unknown amount of true positives. This
was done in exploratory mode to assess the upper limit of
hit frequencies unless stated otherwise.
BGC clusters. We analyzed all 1409 characterized BGCs
from the MIBiG database and found roughly a third (465),
a quarter (348) and 12% (162) have at least one gene match
to models from core gene, known resistance or both re-
spectively. For core genes this is largely attributed to cell
envelope, amino acid and protein synthesis, and energy
metabolism genes. In comparison, default mode, which
lacks protein families likely involved in biosynthesis, trans-
port and regulation, showed <15% of clusters have a core
gene match with a dramatic reduction in cell envelope and
primary metabolism categories (Supplementary File S7).
Additionally, multiple hits in the same cluster are rare
and, if present, likely indicate inaccurate cluster boundaries
rather than cluster participation.With respect to total genes
present,<3.7 and 1.9% are marked as core gene and known
resistance hits respectively.
Complete genomes. We then analyzed 200 complete Acti-
nobacteria genomes, publicly available through NCBI,
though the ARTS pipeline and detected 489 core genes per
genome, on average, with only one or two genes showing
three or more selection criteria (Supplementary File S8).
Approximately 5% of core genes are highlighted for each
criterion with the exception of phylogeny, which shows an
average of 26% of all core genes highlighted. Although this
initially seems high, this rate is similar to other HGT es-
timates of about 35% HGT for Actinobacteria (28). This
shows that multiple screening criteria should be used for
more confident target predictions. The occasional high
counts seen in exploration mode (Supplementary File S9)
can be easily and rapidly filtered by the manageable output
page. Besides cross referencing with multiple criteria, single
criteria hits can be narrowed by several properties such as
gene prevalence, copy number statistics and function. This
can dramatically filter hits and allows for expert review by
the researcher. Likewise, high core hits in BGCs are eas-
ily screened using the visual annotation. Figure 3A shows
added coloring to highlight multiple criteria, and hits are
also seen more central in the predicted cluster. Where many
core genes are captured by inaccurate cluster boundaries, as
in Figure 3B, inspection can serve not only to screen possi-
ble hits but also to help define true cluster boundaries, which
remains a largely unresolved challenge when dealing with
bacterial BGCs.
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Figure 3. ARTS cluster visualizations from example genome Streptomyces roseochromogenes DS 12.976 where core genes are shown in yellow, known
resistance in green and hits for both shown in purple. (A) Purple: positive control of resistant gyrB, Green: DNA topoisomerase IV (B) Example of cluster
boundaries capturing core genes not associated with the cluster.
Positive controls
In order to test ARTS, we performed an extensive liter-
ature search and analyzed all known examples of BGCs
and available bacterial genomes, that contained known ex-
amples of resistant target genes. Out of the 26 identified
clusters from known examples within the MIBiG database,
ARTS detected 22 clusters with resistant targets in explo-
ration mode (Supplementary File S10). Three undetected
cases were due to missing specific DNA glycosylation and
CoA reductase models in both the core and known resis-
tance set. The last missed case, the resistance conferring
23S rRNA methyltransferase, was identified in clusters for
Erythromycin and Pikromycin but not Avilamycin due to
its significantly shorter sequence length and low homology
score. The default search mode showed that 3 positive cases
for FabB/F were not detected. Both gene families are fre-
quently used for the biosynthesis of secondary metabolites
with no possibility at the moment to easily distinguish in sil-
ico if they are involved in resistance or biosynthesis. How-
ever, with expert review in exploration mode these cases
were detected.
The literature search for self-resistance mechanisms that
had genomes of at least draft quality available yielded 14
cases, all of which were processed with ARTS. All cases
except for the resistant FabB/F showed an ARTS hit (Ta-
ble 1), which is detected in exploration mode using reduced
cutoffs. Two cases of rpoB resistance, single copy mutants
not present in a BGC, were marked as known resistant
targets with no other criteria shown. In the case of Ri-
fampicin however, the duplicated resistance conferring rpoB
was detected. The results of anARTS analysis ofSalinispora
tropica CNB-440, the producer of salinosporamide A, (29),
shows positive hits for all the criteria tested. The -subunit
of the proteasome is a known target of salinosporamide A
and the producing cluster contains a resistant copy local-
ized within the operon (15). The incorporated models of
known resistant targets highlights the gene to indicate that
both core and resistant targetmatcheswere found. From the
phylogeny view the resistant copy is quickly seen as having
origins from outside its species and is marked for potential
HGT.
Distant genomes
Although ARTS is so far specialized for actinobacterial
genomes, it can also be applied to organisms that are not
part of the reference phylum, as demonstrated by the posi-
tive results for all three examples from Firmicutes and Pro-
teobacteria (Table 1). One example, theAgrocin 84 producer
Agrobacterium radiobacter K84, showed a duplicated resis-
tant Leu-tRNA synthetase located on the pAgK84 plasmid
that was detected but with no cluster predictions present.
Further investigation showed the producing cluster is in-
deed part of the plasmid (30) and an extended BGC pre-
diction using the ClusterFinder (31) algorithm yielded a
putative 9kb segment which did not include this resistance
gene. By highlighting potential resistance outside of pre-
dicted clusters, this example shows howARTS can serve not
only as a cluster prioritization tool but also as an orthogo-
nal detection method to complement current methods.
DISCUSSION AND CONCLUSION
With ARTS we leveraged the recent advancements in BGC
detection, phylogenetic reconstruction and HGT predic-
tion to automate several analyses of target-directed genome
mining methods into a single computationally inexpen-
sive workflow. In addition to the standard target-directed
screening of known resistance models, we have included
criteria and tools for the rapid exploration of potentially
novel resistance targets. While these criteria do not directly
imply resistance, for example duplications due to adaptive
biosynthesis, it has been shown that integration of multi-
ple criteria can serve to highlight those involved in resis-
tance. Two different screening modes, as well as rapid post
filtering functions that are provided, allow for the fast and
easy exploration of putative novel targets. This allows for
the robust searching of bacterial genomes and provides util-
ity beyond target prediction. In explorationmode for exam-
ple, the detection algorithm includes genes that have been
duplicated from central metabolism and have been repur-
posed for the biosynthesis of secondary metabolites. Indeed
these gene expansions have been shown to be a valuable
cluster detection technique as demonstrated with the Evo-
Mining (11,32) method by highlighting clusters with po-
tentially novel chemistries, such as the recent identification
of arseno-organic natural products in the model actino-
mycetes Streptomyces coelicolor and Streptomyces lividans
(11).
This iteration of ARTS is currently focused onActinobac-
teria but has shown to extend to other phyla as well. We
have constructed the pipeline to work easily with alternative
user generated reference sets and are currently working to
expand these sets for other taxa. Prioritizing putative clus-
ters with an extra layer of antibiotic potential is the main
purpose. However, examples have shown that it can also be
useful in helping to define cluster boundaries. Furthermore,
its use as an orthogonal cluster detection method and high-
lighting unknown or repurposed functions of biosynthetic
enzymes is an interesting possibility. Mainly, we hope the
server will provide broader access to these methods with a
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Table 1. Positive examples of genomes with known self-resistance mechanisms analyzed with ARTS default mode
Hits to ARTS criteria are shown as; D: Duplication, B: BGC proximity, P: Phylogeny, R: Resistance model. Rows in gray indicate non-actinobacterial
genomes where phylogeny criteria is not applicable and tan rows indicate resistance that is not within a BGC. Notes marked with stars are explained in the
bottom row.
higher throughput of clusters and organisms screened to ac-
celerate the discovery of competitive antibiotics.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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